Tag: FDA bioequivalence
Partial AUC: Advanced Bioequivalence Measurements Explained
Jan, 10 2026
Partial AUC is a precise pharmacokinetic tool used to assess bioequivalence in complex drug formulations where traditional metrics fail. It measures drug exposure during critical time windows to ensure safe, effective generic alternatives.
In Vivo vs In Vitro Bioequivalence Testing: When Each Is Used
Dec, 19 2025
In vivo and in vitro bioequivalence testing are two key methods used to prove generic drugs work like their brand-name counterparts. Learn when each method is required, how they differ in cost and accuracy, and how regulators are shifting toward lab-based testing for safer, faster approvals.